Jeffrey M. Leiden, Director of Odyssey Therapeutics ODTX, has filed 1 purchase and 36 sales on the open market. Over the past 12 months that comes to a net sale of $60.8M. The latest trade was on 05/11.

JL

JL

Jeffrey M. Leiden

Director

Company

Odyssey Therapeutics ODTX

First filing

23/02/03

Trades

75 trades

Buys / sales

1 / 36

12-month net buying

−$60.8M

Last trade

05/11

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Odyssey TherapeuticsODTX	Open-market buy	05/08	05/11	5,000 sh	$20.00	$100,000	+1.9%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/12/03	25/12/05	63,781 sh12 trades	$449.20avg.	$28,650,336.65	−72.6%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	25/11/13–25/11/14	25/11/17	73,292 sh5 trades	$440.60avg.	$32,292,319.86	−75.3%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/08/30	24/09/04	3,784 sh	$499.00	$1,888,216	−27.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/14–24/02/15	24/02/16	9,011 sh2 trades	$419.10avg.	$3,776,528.04	−33.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/02/12–24/02/13	24/02/14	3,393 sh3 trades	$419.42avg.	$1,423,104.12	−11.2%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	24/01/08	24/01/10	6,648 sh	$419.07	$2,785,977.36	−73.3%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/12/13	23/12/15	13,354 sh2 trades	$399.42avg.	$5,333,799.14	−59.5%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/10/16	23/10/18	12,962 sh	$374.00	$4,847,788	−36.6%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/05/05–23/05/08	23/05/09	2,004 sh3 trades	$349.25avg.	$699,887.34	−5.4%
Vertex PharmaceuticalsVRTX	Open-market sale10b5-1 plan	23/05/02–23/05/03	23/05/04	10,958 sh6 trades	$349.98avg.	$3,835,061.76	−22.7%